mHealth Fysieke Activiteitsinterventie voor jonge overlevenden van kanker (AYA-PACT)
Adolescenten en jongvolwassenen die lichamelijk actief worden na kankeronderzoek
In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Gedetailleerde beschrijving
Background:
There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.
Aim:
Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.
Methods:
The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.
Studietype
Studietype
Inschrijving (Werkelijk)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Alberta
-
Calgary, Alberta, Canada, T2N5G2
- Arthur J.E. Child Comprehensive Cancer Centre
-
Edmonton, Alberta, Canada, T6G2H9
- University of Alberta
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Lives in Alberta
- Diagnosed with invasive malignancy in Alberta
- Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
- Have the ability to read, write and speak English
- Have access to the Internet on at least a weekly basis
- Have a mobile phone with a text messaging plan
- Willing to be randomized to either arm.
Exclusion Criteria:
- Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
- Currently pregnant or planning to become pregnant within the next 6 months
- Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Experimenteel: mHealth Physical Activity Intervention
The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline. |
The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff. |
|
Geen tussenkomst: Control
Controls received "standard of care" from their medical team and were not provided with any physical activity guidance. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Tijdsspanne: Baseline to 12 months
|
Measured by ActiGraph |
Baseline to 12 months
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Tijdsspanne: Baseline to 6 months and 24 months.
|
Measured by ActiGraph |
Baseline to 6 months and 24 months.
|
|
Changes in weekly minutes of sleep
Tijdsspanne: Baseline, 6 months, 12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months, 12 months, 24 months
|
|
Changes in weekly minutes of sedentary time
Tijdsspanne: Baseline, 6 months,12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months,12 months, 24 months
|
|
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Tijdsspanne: Baseline, 12 months, 24 months.
|
Met-Hours per week and hours per week of moderate-vigorous physical activity |
Baseline, 12 months, 24 months.
|
|
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Tijdsspanne: Baseline, 6 months,12 months
|
Global score range is 0 to 23 where higher scores indicate worse sleep quality |
Baseline, 6 months,12 months
|
|
Changes in weight
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms |
Baseline, 6 months,12 months
|
|
Changes in body mass index (BMI)
Tijdsspanne: Baseline, 6 months,12 months
|
Measured by combining height (meters) and weight (kilograms) and reported in kg/m2 |
Baseline, 6 months,12 months
|
|
Changes in waist and hip circumference
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in centimeters |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Tijdsspanne: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Tijdsspanne: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in grip strength
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms using a hand dynamometer |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular strength
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular endurance
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular strength
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular endurance
Tijdsspanne: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in frailty
Tijdsspanne: Baseline, 6 months,12 months
|
Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better physical health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-physical subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate less pain |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) General Health subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Vitality subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher vitality |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 Mental Health subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Physical subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 72. Higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 36 where higher scores indicate poorer cognition |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 52 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Comprehensive Score for Financial Toxicity (COST)
Tijdsspanne: Baseline, 6 months,12 months
|
Score range is from 0 to 44 where higher scores indicate better financial wellbeing |
Baseline, 6 months,12 months
|
|
Changes in fear of cancer recurrence - short form (FCRI-SF)
Tijdsspanne: Baseline, 6 months, 12 months
|
Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity. |
Baseline, 6 months, 12 months
|
|
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Tijdsspanne: Baseline, 6 months, 12 months.
|
Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television. |
Baseline, 6 months, 12 months.
|
|
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Tijdsspanne: Baseline, 6 months, 12 months.
|
Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity. |
Baseline, 6 months, 12 months.
|
|
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Tijdsspanne: Baseline, 6 months, 12 months
|
Range of scores from 11 to 55 with higher scores indicated higher self-efficacy. |
Baseline, 6 months, 12 months
|
|
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Tijdsspanne: Baseline, 6 months, 12 months.
|
Range of scores from 10 to 50 with higher scores indicating more support. |
Baseline, 6 months, 12 months.
|
|
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Tijdsspanne: Baseline, 6 months, 12 months.
|
Range of scores from 12 to 60 with higher scores indicating more self-monitoring. |
Baseline, 6 months, 12 months.
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Medewerkers
Medewerkers
Onderzoekers
Onderzoekers
- Studie directeur: Miranda Fidler-Benaoudia, PhD, Cancer Care Alberta
- Hoofdonderzoeker: Christine Friedenreich, PhD, Cancer Care Alberta
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studie start
Primaire voltooiing (Werkelijk)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
Andere studie-ID-nummers
- HREBA.CC-20-0397
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .